MBX Biosciences, Inc.
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 14.09% | -1.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.73% | -17.81% | |||
| Operating Income | -9.73% | 17.81% | |||
| Income Before Tax | -11.37% | 18.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.37% | 18.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.37% | 18.71% | |||
| EBIT | -9.73% | 17.81% | |||
| EBITDA | -9.81% | 17.80% | |||
| EPS Basic | -8.91% | 18.79% | |||
| Normalized Basic EPS | -8.93% | 18.80% | |||
| EPS Diluted | -8.91% | 18.79% | |||
| Normalized Diluted EPS | -8.93% | 18.80% | |||
| Average Basic Shares Outstanding | 2.25% | 0.10% | |||
| Average Diluted Shares Outstanding | 2.25% | 0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||